James Edgemond | Chief Financial Officer |
Martine Rothblatt | Chairman, Chief Executive Officer |
Michael Benkowitz | President, Chief Operating Officer |
Chris Shibutani | Cowen |
Liana Moussatos | Wedbush Securities |
Jessica Fye | JPMorgan |
Terence Flynn | Goldman Sachs |
Good morning and welcome to the United Therapeutics Corporation first quarter 2019 earnings call. My name is Michelle and I will be your conference operator today. All participants will be in listen-only mode until the question-and-answer session. [Operator Instructions]. I will now to turn the conference call over to James Edgemond, Chief Financial Officer of United Therapeutics.